Spontaneous development of autoimmune uveitis Is CCR2 dependent

Area of Science:

• Immunology
• Ophthalmology
• Autoimmunity

Background:

• Noninfectious posterior uveitis treatment is challenging due to a lack of suitable human disease models.
• Mice lacking the autoimmune regulatory gene Aire spontaneously develop autoimmune uveitis, mimicking human disease.
• This Aire knockout (KO) mouse model is valuable for studying uveitis mechanisms and therapies.

Purpose of the Study:

• To investigate the role of C-C chemokine receptor type 2 (CCR2) in the pathogenesis of autoimmune uveitis.
• To evaluate CCR2 as a potential therapeutic target for autoimmune uveitis.

Main Methods:

• Utilized the Aire knockout (KO) mouse model of autoimmune uveitis.
• Assessed the impact of CCR2 deficiency on immune cell infiltration and retinal destruction.
• Investigated the contribution of CCR2-dependent mononuclear cell migration to retinal inflammation and damage.

Main Results:

• CCR2 plays an essential role in the development of autoimmune uveitis in Aire KO mice.
• Loss of CCR2 function significantly reduced immune cell infiltration into the retina.
• CCR2 deficiency rescued the retina from inflammatory destruction and photoreceptor loss.
• CCR2-expressing mononuclear cells were critical for driving retinal inflammation and recruiting CD4(+) T cells.

Conclusions:

• The CCR2 pathway is crucial for the pathogenesis of autoimmune uveitis.
• Blocking CCR2 function presents a promising therapeutic strategy for treating autoimmune uveitis.
• Targeting CCR2 may effectively reduce immune cell infiltration and prevent retinal damage in uveitis patients.